Determining Best or Inferior Drug(s) Using an Adaptive Platform for Cryptogenic Sensory Polyneuropathy

Authors

  • Richard J. Barohn University of Missouri School of Medicine
  • Charles K. Abrams The University of Chicago Medicine
  • Jeffery A. Allen University of Minnesota School of Medicine
  • Komal Ashraf University of Missouri School of Medicine
  • Jose David Avila Geisinger Medical Center
  • Alexandru Barboi Northshore University HealthSystem
  • Gillian Bartlett University of Missouri School of Medicine
  • Janine Bensman Overland Park, Kansas
  • Suur Biliciler The University of Texas Health Science Center at Houston McGovern Medical School
  • Thomas H. Brannagan III Columbia University, Vagelos College of Physicians and Surgeons
  • Alexandra Brown The University of Kansas Medical Center
  • Brian Callaghan University of Michigan
  • Michael S. Cartwright Wake Forest School of Medicine
  • Deandra Cassone University of Missouri School of Medicine
  • Nizar Chahin Oregon Health & Science University
  • Jasvinder Chawla Loyola University Medical Center
  • Mary Christie University of Missouri School of Medicine
  • Miguel Chuquilin University of Florida College of Medicine
  • Michael P. Collins Froedtert and the Medical College of Wisconsin
  • Erin Corriveau The University of Kansas Medical Center
  • Anahita Deboo Lewis Katz School of Medicine at Temple University
  • Mazen Dimachkie The University of Kansas Medical Center
  • John J. England Louisiana State University Health Sciences School of Medicine
  • Joseph Americo Fernandes University of Nebraska Medical Center
  • Miriam Friemer The Ohio State University Wexner Medical Center
  • Tracy Fuemmeler University of Missouri School of Medicine
  • Byron Gajewski The University of Kansas Medical Center
  • Stefanie Geisler Washington University School of Medicine in St. Louis
  • Laura Herbelin Overland Park, Kansas
  • Steven Herskovitz Montefiore Medical Center / Albert Einstein College of Medicine
  • Neil Holland Geisinger and Geisinger Commonwealth School of Medicine
  • Carlayne E. Jackson University of Texas Health Science Center at San Antonio
  • Yaswitha Jampani University of Missouri School of Medicine
  • Vern C. Juel Duke University School of Medicine
  • Kim Kimminau University of Missouri School of Medicine
  • Richelle Koopman University of Missouri School of Medicine
  • David Lacomis University of Pittsburgh Medical Center
  • Maxwell Levy Tulane University School of Medicine
  • Rabia Malik Rush University Medical Center
  • Vasanthi Mandhadi University of Missouri School of Medicine
  • Daniela Maria Menichella Northwestern University Feinberg School of Medicine
  • Julie Miller University of Missouri School of Medicine
  • Shamita Misra University of Missouri School of Medicine
  • Abu Saleh Mohammad Mosa University of Missouri School of Medicine
  • Sharon P. Nations University of Texas Southwestern Medical Center
  • Xiaofan Niu University of Missouri School of Medicine
  • Jeff Ordway University of Missouri School of Medicine
  • Mamatha Pasnoor The University of Kansas Medical Center
  • Amanda Peltier Vanderbilt University Medical Center
  • Robert Pierce University of Missouri School of Medicine
  • Michael T. Pulley University of Florida College of Medicine Jacksonville
  • Kourosh Rezania The University of Chicago Medicine
  • Jessica Robinson-Papp Icahn School of Medicine at Mount Sinai
  • Katherine Ruzhansky Medical University of South Carolina
  • Anne Sales University of Missouri School of Medicine and VA Ann Arbor Healthcare System, Ann Arbor, Michigan
  • Khema Ram Sharma University of Miami Miller School of Medicine
  • Amro Stino University of Michigan
  • Xiaowei W. Su Penn State Health M.S. Hershey Medical Center
  • Tony Sun United Healthcare
  • Andrea Swenson University of Iowa Hospitals and Clinics
  • Pariwat Thaisetthawatkul University of Nebraska Medical Center
  • Sujata P. Thawani New York University Langone Health
  • Rebecca Traub University of North Carolina School of Medicine
  • Lemuel R. Waitman University of Missouri School of Medicine

DOI:

https://doi.org/10.17161/rrnmf.v3i2.18133

Keywords:

letter

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

Downloads

Published

2022-06-22

Issue

Section

Grant proposals (Funded or unfunded)

How to Cite

Barohn, R. J., Abrams , C. K., Allen , J. A., Ashraf, K., Avila, J. D., Barboi, A., Bartlett, G., Bensman, J., Biliciler , S., Brannagan III, T. H., Brown, A., Callaghan, B., Cartwright , M. S., Cassone, D., Chahin, N., Chawla, J., Christie, M., Chuquilin, M. ., Collins, M. P., … Waitman, L. R. (2022). Determining Best or Inferior Drug(s) Using an Adaptive Platform for Cryptogenic Sensory Polyneuropathy. RRNMF Neuromuscular Journal, 3(2), 45-98. https://doi.org/10.17161/rrnmf.v3i2.18133